| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $8.8M | -48.4% |
| SG&A Expense | $12.0M | -34.8% |
| Operating Income | -$12.7M | +78.5% |
| Interest Expense | $16K | +41.3% |
| Net Income | -$14.6M | +75.0% |
| EPS (Basic) | -$21.00 | -121.8% |
| EPS (Diluted) | -$21.00 | -121.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.4M | -83.5% |
| Accounts Receivable | $93K | — |
| Current Assets | $3.4M | -63.8% |
| Total Assets | $5.4M | -53.9% |
| Current Liabilities | $2.5M | -79.8% |
| Total Liabilities | $2.7M | -86.2% |
| Stockholders' Equity | $2.7M | +135.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$22.3M | +30.8% |
| Capital Expenditures | $69K | +0.0% |
| Investing Cash Flow | -$10.3M | +0.0% |
| Financing Cash Flow | $15.7M | -64.8% |
| Free Cash Flow | -$22.4M | +30.7% |